Natural killer T cell-based cancer immunotherapy

Hans J J van der Vliet; Steven P Balk; Mark A Exley

doi:10.1158/1078-0432.CCR-06-1392

Natural killer T cell-based cancer immunotherapy

Hans J J van der Vliet, Steven P Balk, Mark A Exley

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	5921-3
Number of pages	3
Journal	Clinical Cancer Research
Volume	12
Issue number	20 Pt 1
DOIs	https://doi.org/10.1158/1078-0432.CCR-06-1392
Publication status	Published - 15 Oct 2006
Externally published	Yes

Access to Document

10.1158/1078-0432.CCR-06-1392

Cite this

@article{ef32ea952c644e8a98ee8203218ab7eb,

title = "Natural killer T cell-based cancer immunotherapy",

keywords = "Clinical Trials, Phase I as Topic, Humans, Immunotherapy/methods, Killer Cells, Natural/immunology, Lymphocyte Transfusion/adverse effects, Neoplasms/therapy",

author = "{van der Vliet}, {Hans J J} and Balk, {Steven P} and Exley, {Mark A}",

year = "2006",

month = oct,

day = "15",

doi = "10.1158/1078-0432.CCR-06-1392",

language = "English",

volume = "12",

pages = "5921--3",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "20 Pt 1",

}

TY - JOUR

T1 - Natural killer T cell-based cancer immunotherapy

AU - van der Vliet, Hans J J

AU - Balk, Steven P

AU - Exley, Mark A

PY - 2006/10/15

Y1 - 2006/10/15

KW - Clinical Trials, Phase I as Topic

KW - Humans

KW - Immunotherapy/methods

KW - Killer Cells, Natural/immunology

KW - Lymphocyte Transfusion/adverse effects

KW - Neoplasms/therapy

U2 - 10.1158/1078-0432.CCR-06-1392

DO - 10.1158/1078-0432.CCR-06-1392

M3 - Article

C2 - 17062661

VL - 12

SP - 5921

EP - 5923

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 20 Pt 1

ER -